II
`
`.250. Murray P, Schlessel..ooanJJ, Sr.adel BV,
`Shenghan L, Oral contraceptives and
`breast c:a.ncer risk in women with a
`f.unily history of bre.ut cancer, Am j
`Oh1kt Gynuo! 73:977, 1989.
`
`251. Schildlaaut
`JM, Hulka BS,
`Willci.nson WE, Oral conuacepcivcs
`and breast cancer: a case-conuol srudy
`with
`hospital
`and. comm~ity
`controls, Obrut ~co/76:395, 1990.
`
`252. Coll.a.boracive Group on Honnona.l
`Factors i.o. Breast Cancer, Breast
`cancer and hormonal conuaccptives:
`collaborative reanalysis of individual
`data on 53,297 women with brC":!St
`cancer :and 100,..239 women without
`breast cancer from 54 epidem.iological
`srudic:s, Lanc,·t 347:1713, l996.
`
`253. Collaborative Group on Hormonal
`Factors in Breast Cancer, Breast
`cancer and hormonal contract:ptivc:s:
`furd1cr results, Contrtu:tption 54:1 S,
`1996.
`
`254. Lambe M, Hsieh C, Trichopoulos D,
`Ekbom A, Pavia M, Adami H-0,
`Trans.ie.nt increase in me risk of breasr
`cancer afrer giving birth, New Eng!]
`Md331:5, 1994.
`
`255. Guinee VF, Olsson H, Moller T, Hess
`KR. Taylor SH, Fahey T, Gladikov
`JV, van d.e.n Blink' ]W; Bonichon F.
`Dische S, et al, Effect of pregnancy on
`prognosis for young women with
`breast cancer, .Uznut 343:1587, 1994.
`256. Kroman N, Wob.lfarr J, Andwen
`KW, Mouriud.sen HT, Wesrer~d
`U, Melbye M, Tune since childbirth.
`and prognosis in primary breast
`cancer: population based srudy, Br
`M(dj315:851 , 1997.
`257. Rosenberg L, Palmer JR, Clarke EA,
`Shapiro S, A casc-concrol srudy of me
`risk of breast o.ncer in relarion to oral
`contraceptive use, Am j Epidmtio/
`136:1437. 1992.
`
`(,
`d
`
`l-
`g
`rt
`
`P'>
`)-
`
`r,
`
`P, ,_
`
`n
`·n
`
`~r
`sr
`
`5,
`
`258. Magnusson CM, Persson I.R, Baron
`JA, Ekbom A, Bergstrom R Adami
`H-0, The role of reproductive factors
`and use of oral contraeepcives in the
`aetiology of breast cancer in women
`aged SO to 74 years, lnt j Cancer
`80:231, 1999.
`
`259. Ursin G, Henderson BE, Haile RW,
`Pike MC, Zhou N, Dicp A. Bernsre.i.n
`L, Does oral contraceprive usc Increase
`the risk of breast cancer in women
`with BRCA1/BRCA2 mutations more
`than in otber women?, c~:nccr RLJ
`57:3678, 1997.
`
`260. American Cancer Sociery, Cancer
`facts &
`1999 - 2000,
`figures -
`http://www. cancer. orglstatirtio/.
`
`::-.
`
`261. Green A, Oral contraceptives and skin
`neoplasia, Contractpti(l11 43:653, 1991.
`
`262. Hannaford PC, Villard.-Ma.ckinrosh
`L, Vessey MP, Kay CR. Oral contra(cid:173)
`eeprives and malignant melanoma, Br
`J Canca 63:430, 1991.
`
`263. Milne R, Vessey M, The association of
`oral comra.ception with kidney cancer,
`colon cancer, gallbladder canc~r
`(including omaheparic bile duct
`cancer)
`and
`pituitary
`rumors,
`Contractption 43:667, I 991.
`
`264. Berkowitz R.S, Bt:rnsrein MR.
`Harlow BL. Rice TW, Lage JM,
`Goldstein DP. Cramer DW, Case(cid:173)
`control srudy of risk Facwrs for partial
`molar pregnancy, Ant J Obrta Gyrurol
`173:788, 1995.
`
`265. Hom-Ross PL, Morrow M, ljung
`BM, Men.su:ual and reproductive
`factors For taliv:uy gland cancer risk in
`women, Epidemiology 10:528, 1999.
`
`266. Martinez ME, Grodste in
`F,
`Giov.w.nn.cci E, Coldicz GA, Spcizcr
`FE, Hennekcns C, Romer B, Willett
`WC, Stampfer MJ, A prospective
`srudy of reproducrive facton>, oral
`contraceptive use, and 6sk of colo(cid:173)
`caJ'ICc:r, Canur EpidLmiol
`rectal
`Biomark= Prcv 6:1, 1997 .
`
`-..... ~
`
`'
`
`·':"·
`
`•: , .
`. .
`
`' ....
`
`.·.'· ....
`
`·.· · . . .
`
`r.
`
`, .:. . ,
`
`Oral Contraception
`
`267. Franceschi S, La Vecch.ia CL, Oral
`coocraceptives and colorcct:al tumors.
`A review of epidemiologic srudies,
`Contraception 58:335, 1998.
`
`268. Janerich DT, Dugan JM, Standfast:
`SJ, Strice L, Congeniral heart disease
`and prenatal expm;ure to otogenous
`sO! hormoo~. Br Medj i:l058, 1977.
`269. Nora JJ, Nora AH, Blu J, lngr.un J,
`Foster D, Exogenous progestogen and
`esuoge.n implicated in binh defects,
`JAMA 240:&37, 1978.
`270. Heinonen OP. Slone D, Mooson RR,
`Hook ER, Shapiro S, Cardiovascular
`binh defects in antenatal ocposure w
`female sex hormones, N~ Englj Md
`296:67, 1976.
`271. Simpson JL, Phillips OP, Sperm(cid:173)
`icides, hormonal concraception and
`congenital malformations, Adv
`Contr!Ueption 6:141, 1990.
`272. Michaelis J, Michaelis H, Gluck E,
`KoUer S, Prospocrive study of
`sus peered associa cions berwec:n cenain
`drugs ad.mini.stered during early preg(cid:173)
`nancy and congeo.ital malformations,
`Tt:rP.kJlogy 27:57, 1983.
`
`273. Bracken MB, Oral contraceptio.n and
`congenital malformations in offspring:
`a review and meta-analysis of rhe
`prospective srudies, Obm:t Gy=col
`76:552, 1990.
`
`L, Tseng AL.
`274. R.ama.n-Wilms
`Wighardt S, Einacson. TR, Koren G,
`Feral genital effecrs of first trimester
`sa hormone ocposure: a mera(cid:173)
`analysis, Obm.rGyneco/85:141 , 1995.
`
`275. Ressequ.ie LJ, Hick JF, Bruen JA,
`Noller KL, O'Fallon WM, Kurland
`U, Congenital malformations among
`offspring exposed in mero to proges(cid:173)
`tins, Olsted Counry. Minnesota,
`1936-1974,Fmi/ Sr.ai/43:514, 1985.
`
`Mylan v. Warner Chilcott IPR2015-00682
`WC Ex. 2005, Pg. 111
`
`

`
`A Clinical Guide for Contraception
`
`276. Kan Z, Lancet M, Skornik J,
`Chemkc J, Mogilemer B, K!inberg
`M, Teratogenicity of progesroge.ru
`give!ll during the fust rrimester of preg(cid:173)
`nmcy, Obitet Gyneco/65:715, 1985.
`
`286. Vessey M, Doll R. Peto R, Jobnson B,
`Wtggins P, A long-term follow-up
`smdy of women using different meth(cid:173)
`ods of cono:acept.ion -
`an interim
`rep on, j Bw>oc Sci 8:373, 1976.
`
`277. Vessey MP, Wright NH, McPherson
`K, Wiggins P, Fenility after ~oping
`dif&renc mccbods of concraccpti.on, Br
`Medj i:265, 1978.
`
`287. Royal College of General Prac(cid:173)
`titioners, The outcome of p regnancy.
`in former oral conuacepcive users, Br J
`Obsta Gyno.m/83:608, l976.
`
`278. Vessey MP, Smith MA, Yates D ,
`Rerum of feniliry after discontinua(cid:173)
`cion of oral oontracc:ptives: i.nllue.ncc:
`of age and parity, Br J Fam P!.ann
`11:120, 1986.
`
`279 . Linn S, Schoenbaum SC, Monson
`RR. Rosner B, Ryan. KJ, Delay in
`conception for former 'pill' users,
`lAMA 247:629, 1982.
`
`280. Bracken MB, Hellenbrand KG,
`Holford TR, Concepcion dday ·aftC£
`oral contraceptive usc: the effect of
`estrogen dose, hrtil Steril 53:21,
`1990.
`
`281. Bagwell MA, Coker AI., Thompson
`SJ, Baker ER. Addy CL, Primary
`inferrili ry and oral contraceptive
`steroid use,Fmi!Ste:ril63:1l61, 1995.
`282. Rot:h.man KJ, Fetal loss, cwinning, and
`birth weight afrer oral-cont.racepcive
`use, N!tW Eng{] Med297:468, 1977.
`
`283. Ford JH, M2cCormac L, Pregnancy
`and life5ryle srudy: the long-[erm use
`of me contraceptive pill and !he risk of
`age-rdaced misc.an:iage, Hum Rtprod
`10:1397, 1995.
`284 . Roclunan KJ, Liess J, Gender of
`offSpring afcer oral-conuacepcive use,
`Nro;Engl] Mcd295:B59, 1976.
`
`285 . Magi docS, Poalti H , Harlap S, Baras
`M, Long-cerro fullow-up of childre!ll
`whose mochers usoo oral conuacep(cid:173)
`rivc:s prior co coocraccpcion, Contra(cid:173)
`aption J-9:203, 1984.
`
`2S8. Di.az S, Peralta 0, Jucz G, Herrems ·
`C, Casado ME, Salvatierra AM,
`Mican.da P, Dwn E, Cro:utto HB,
`Fertility cc:gularion in nursing women: .
`III. Short-term influence of a low-dose
`combined oral conuacepcive upon
`lactation and infant growth, Contra(cid:173)
`ception 27:1, .1982.
`
`289. Croxatto HB, Di.az S, Peralta 0, Juez
`G, - Herrero& C, Casado ME,
`Salvatierra AM, Micanda P, Durn E,
`Fertility ;egulation in nursing women:
`IV Long-cerm i.nlluence of a low-dose
`combinoo oral oontracc:pcive ioiciaced
`at day 30 posqn.Hum upon laaacion
`and child growth, Contractption
`27:13, 1983.
`
`290. Peralra 0 , Diaz S, Juez G, Herreros
`C, Casado ME, Salvatierra AM,
`Miranda P, Dum E, Cro:xacro HB,
`Fertility regukcion in nursing women:
`V LoJlg-ierm influence of a low-dose
`combined o.(:!.! conrraceptivc initiated
`ac d.ay 90 postpa.n:um upon lactation
`infanc growth, Contraception
`and
`27:27, 1983.
`
`291 . Berrahec SS, S.hikary ZK, Toddyw.Jla
`VS, Toddywalla SP, Patel D, Saxena
`BN, Transfer of norelhistc:rone (NET)
`and levonorgestrel (LN G) from a
`single cablet imo me infant's circula(cid:173)
`t:he modle r's milk,
`tion · through
`Crmtracrytion 35:517, l987.
`
`.,
`,,,.:..
`
`-.!.
`
`. ·. ~
`
`~·
`
`··: ·
`
`-
`
`292. WHO, Special Programme of
`R~earch, Devdo.pmeo t,
`and
`R~ea.cch Training
`in HumaJl
`Reproduccio'?-, Task Force on Oral
`Contraceptives, Effects of hormonal
`cont.J<~cepcivc:S on milk volume and
`iQ.fanc growth, Contraception 30:505,
`1984.
`
`293. Nilsson S, Mdbin T, Hofvander Y,
`SWldelin C., Valcucin J, Nygren KG, .
`Long-term .follow-up of children
`breast-fed by mothC£s using oral
`comr:aceptives, Conmutption 34:443,
`1986.
`.
`
`294. ~pbell OM, Gray RH, Char(cid:173)
`acrcri.stics
`and decerminanrs of
`postpartum ovarian
`function
`in
`women in 'me Unired S[aces, Am J
`. Obrrn Gyn«afl69:55, 1993.
`
`295. Labbok MH, Hight-Laukaran V,
`Peterson AE, Fletcher V, von Henzen
`H, Van Look PFA, Mulciceocer srudy
`of -the laccacional amenorrhea method
`(LAM): I. Efficacy, duration, and
`implicarion~ for clinical application,
`Contraception 55:327, 1997.
`
`296. Vi~oess CM, KenJle<iy I<I, Gross BA.,
`Parenceau~Carrea.u S, Flynn AM,
`Bro\vn JB, Fertility of fully breast(cid:173)
`in
`feeding
`"'.'Omen
`the
`early
`postpartum ·period, Ohstu Gynecol
`89:164, 1997.
`
`297. Diaz S, Araveua R, ~de!llas H,
`ME, Miranda
`Casado
`P,
`SCb.iappacasse V, Croxarco HB,
`Cono-aceptive efficacy of lacrarional
`amenorrh.ea in urban Chilean women,
`Contractption 43:335, 199 1.
`
`298. Gray RH, Campbell OM, Zacnr HA,
`Labbok MH, MacRae
`SL,
`Eostparrum rerum of 0~3J\ accivlry
`i_n nonbreast:feeding women mooi(cid:173)
`roreCI by urinary assays, J Clin
`Endocrinol Metab 64:645, 1987.
`
`Mylan v. Warner Chilcott IPR2015-00682
`WC Ex. 2005, Pg. 112
`
`

`
`286. Vessey M, DoU R, Peto R, Johnson B,
`Wiggins P, A long-term foUow-up
`srudy of womc:u using diffueot meth(cid:173)
`ods of contraception -
`an interim
`repon,1 BiosocSci 8:373, 1976.
`
`287. Royal CoUege of General Prac(cid:173)
`tiriooc.rs, The omcome of pregnancy
`in former oral contraceptive users, Br 1
`ObJut 0114ecol83:608, 1976.
`
`288. Diaz S, Peralta 0, Jucz G, .Hen-eros
`C, Casado ME, Salvatierra AM,
`Miranda P, Dum E. Croxatoo HB,
`Ferrili.:y regulation in nursing women:
`m. Sbon-rerrn influence of a low-dose
`combined oral cootracepcivc: upon
`lactation a.od infant growili, Conmz(cid:173)
`uption 27: I , 1982.
`
`289. Croxa.tto HB, Diaz $,Peralta 0, Juez
`G, Herreros C, Casado ME,
`Salvatierra AM, Miranda ·p, Durn E,
`Fertility regulation in nursing women:
`IV: Long-wm influence of a low-dose
`combined oral concraceprivc: initiated
`at day 30 ·posrpan:uro upon lactation
`and child growili, Cont:Taccption
`27:13. 1983.
`
`290. Pc.ralta 0, Diaz S, Juez G, Herreros
`C, Casado ME, Salvatierra AM,
`Miranda P, Durn E, Crontto HB,
`Ferciliry rcgulacion in nursing women:
`V. Long-term i.n.fl.uence of a low-dose
`combino:i oral contraceptive initiated
`at day 90 postparrum. upon lactation
`infant growrh, ContrJZuption
`and
`27:27, 1983.
`
`291. Betr-abct SS, Shikary ZK, Toddywalla
`VS, Toddywalla SP. Patel D, Saxena
`BN, Transfer of norc:rhisterone (NET)
`and lcvonorgesad (LNG) from a
`single tablet inro the infant's circula(cid:173)
`tion
`through che mother'& milk,
`Contraception 35:517, 1987.
`
`.,.t•
`
`·"'r
`
`.. -.~.
`
`'f.
`
`. -~.
`
`292. WHO, Special Programme of
`Research,
`Development,
`and
`in Human
`Rcs~ch Training
`Reproduction, Task P<lrce on Oral
`Conu.acepti:ves, Effeas of hormona.l
`contraceptives on milk volume and
`infant growth, Contr!Ueption 30:505,
`1984.
`
`293. Nilsson S, Me.lbin T, Hofvandu Y,
`Sundelin C, Valentin J, Nygren KG,
`Long-term follow-up of children
`breasc-fed by mothers using oral
`contraceptives, Contraupti~n 34:443.
`1986.
`
`294. CampbeU OM, Gray RH, Char(cid:173)
`acterisrics and determinants of
`posrpa.rrum ovarian
`function
`in
`women in the Unicc:d Stares, Am 1
`Obsta Gynrcol169:55. 1993.
`
`295. I..abbok MH, Hight-I..auk.aran. V,
`Perersoo AE, Fletcher V, von Becczen
`H, Van Look PFA., Mulcia:.mer srudy
`of che laaational amenorrhea method
`(LAM): I. Efficacy, duration, and
`implications for clinical applicacion,
`ContrJUeptilm 55:327, 1997.
`
`296. Vtsness CM, Kennedy KI, Gross BA,
`Parenteau-Carceau S, Flynn AM,
`BJ:"own JB, Feniliry of fully breast(cid:173)
`feeding women
`in
`the
`early
`ponpa.m~m period, Obsttt 0necol
`89:164, 1997 .
`
`297. Diu S, Aravcna R, Cardenas H,
`Casado ME,
`P,
`Miranda
`Sch.iappac:a.sse V. Croxatto HB,
`Contraceptive efficacy of lactational
`amenorrhea in urban Chilean womc.n,
`Contr4Ceptum 43:335, 1991.
`
`298. Gray RH, Campbell OM, Za= HA,
`La.bbok MH, M acRae
`SL,
`Posrparrum rerum of ovaria.I) accivicy
`in nonbreastfeeding women moni(cid:173)
`tored by urinary assays,
`j Clin
`Endocrinol Merab 64:645, 1987.
`
`Oral Contraception
`
`199. McCann MF. Moggia AV, Hibbins
`JE, Pons M, Beda:r C, The effects of
`a progestin-on!y oral conuacep1ive
`(levonorgesuel 0.03 eng) on breast(cid:173)
`feeding, Contraception 40:635, 1989.
`
`300. Kennedy KI, Short RV, Tully MR,
`Ptt:marure inaoducrion of progestin(cid:173)
`only contraceptive methods during
`Ltco.tion, Contrauption 55:347, 1997.
`
`301. Pimirary Adenoma Study Group,
`Piruitary adenomas and oral conaa(cid:173)
`ceptives: a multlu.mcr case-conuo}
`srudy; hrtil Stai/39:753, 1983.
`
`302. Shy FKK, McTieman AM, DalingJR.
`Weiss NS, Oral concraceprive use aod
`th~ occurrence of pituitary prolact.ino(cid:173)
`rrus.]AMA 249:2204, 1983.
`303. W.mgrav~ SJ, Kay CR, Vessey MP,
`Oral contraceptives and pituitary
`adenomas, Br Mtd]180:685, 1980.
`
`304. Hulting A-L, Werner S, Hagenfddc
`I<. Oral contraceptives do not
`promote t:he devdopmcnt or growth
`ContrJZu ption
`of prolactinomas,
`27:69, 1983.
`
`305. Core.nbhun B, Donovao L, The safcry
`of physiological estrogen plus proges(cid:173)
`tin replacem ent therapy and oral
`concracepcive therapy in woml!ll with
`pa rhologic.al hyperp rolaccinc.mia, Fmil
`Stml 59:671, 1993.
`306. 1esu G, Vegetti w; Moaa T, .Alagrul
`P, Bianchedi D, Carlucci C, Bianchi
`M, P:u:azz.ici F. Ctosignani PG, Two(cid:173)
`year rreaon~nr with oral conuacepcivc:s
`in
`hyptrprolactinc.mic
`pacients,
`Ctmtraccption 58:69, 1998.
`
`307. Fll{uhjdm M, Ca.rlm om K,
`Amenorrhea
`foUowi ng
`use of
`combined oral conuacepcives, Acta
`Obsra 0necol SCJUJd 52:373, 1973.
`
`Mylan v. Warner Chilcott IPR2015-00682
`WC Ex. 2005, Pg. 113
`
`

`
`A Clinical Guide for Contraception
`
`308. Shearm.an RP, Smith ID, Sracirucal
`analysis of rd.acionship becween oral
`contraceptives, secondary amc:norrhea
`and galactorrhea, J Obiter Gyruutol Br
`ummunw 79:654. 1972.
`
`309. Jacobs HS. Knuth UA, Hull MGR.
`Franks S, Post "piU" amc.norrb.ea -
`cause or coincidence?, Br Med]ii:940,
`1977.
`310. Vessey MP, Han..naford P. Mant J,
`Painrec R, Frith P, Chappel D. Oral
`conrracepcion and eye disease: fmd·
`i.ogs in two large cohon smdies, Br
`M!d j 82:538, 1998.
`
`311. Villard-Mackincosh L, Vessey MP,
`Oral concracepcives and reproductive
`faaors in rnulriple sclerosis incidence,
`Gmmr.cption 47:16 1, 1993.
`
`312. Thorogood M, Hao.naford PC, The
`influence of oral concracepcives on che
`risk of multiple sclerosis, Br j Obstet
`Gy111ucoll05: 1296, 1998.
`
`313, Conello Daly C, Helling-Giese GE,
`Mati JK. Hunce.r DJ, CoDtraceptive
`merhods and rhe tr.Ulsmission ofHN:
`implicacioru for family planning,
`Gmituurin Md 70:110, 1994.
`
`314. Tanecpanicluku1 S, Phuaprad.ir W,
`Chatu.rachinda K. Association of
`contraceptives and HIV-1 infectio.o i!l
`Thai female coiJUnerci.al sex workt:rs,
`.A.UJt N Z J Obm:t Gyruucol 37:86,
`1997.
`
`315. Kapiga SH, Lyamuya EF, Lwihula
`GK, Hunter DJ, Tb.e incidence of
`HIV infection amoog women using
`family planning mechods i.o Dar-e:s(cid:173)
`Siliam, Ta.o:z.ania, AIDS 12:75, 1998.
`
`316. Srcphe.nso.n JM, SysteDUtic review of
`hormooa.l concracepcion and lisk of
`HIV uarumission: wh~ to resist
`mera--an.aly.ils, AIDS 12:545, 1998.
`
`317. Ahma JC, Ch.andca A, Mosher WD,
`Peterson L, Piccinino L, (Centers for
`Disease Conuol and Prevention,
`Nariooal Center For Heach Sracistics),
`Fcrrilicy, family pbnning, and women's
`b.eahh: new data from the 199 5
`Nario.nal Swvey of Family Growth,
`Report No. 19, Series 23, 1997.
`
`318. Westrom I, Incidence, prevalence, and
`crends of acute pelvic inflammatory
`disease and ics consoqueoces in i.odus·
`uialized countries, Am j Obsta
`GyrUcol138:880, 1980.
`
`JP,
`319. Eschenbach DA, Ha.misch
`Holmes KK, Pachogenesis of acuce
`pdvic inflammatOry disease role of
`contra.cepcion and other risk faaors,
`Am] Ob>Ut ~o/128:838, 1977.
`
`320. Rubin GL, Ory WH, Layde PM,
`Oral contraccpcivcs and pdvic in flam.·
`matory disease, Am ] Obstet Gy~Ucof
`140:630, 1980.
`
`P, Kramer DG,
`321. Senan.ayake
`Contraception and the etiology of
`pdvic i.nfuunmatory diseases: new
`perspcccives, Am j Obsw Gyrucol
`138:852. 1980.
`
`322. Panser LA, Phipps WR, Type of oral
`coorrac.eptive in rd.uion to acute,
`initial episodes of pdvic i.nflammarory
`disease, untrauption 43:91, 1991.
`
`323. Svensson L, Westrom L, Mardh P,
`Contracepcives and acuce salpingitis.
`j.AMA 251:2553, 1984.
`
`324. Wolner-Hanssen P, Oral contracep(cid:173)
`tive use modifies rhe manifestations of
`pdvic i.nflamma[Qry disease, Br ]
`Obstet Gynauo/93:619, 1986.
`
`325. Cares Jr W. Washington AE. Rnbi.o
`GL, Peterson HB, T he pill, chlamydia
`and PlD, Fam P/mm Paspm 17:17 5,
`1985.
`
`326. Critchlow CW. Wolner-Hansseu P,
`Eschenbacll DA, Kiviat NB, Koutsky
`LA, Stevens CE, Holmes
`lQ(,
`Determinants of cervical ecropia and
`of cervicitis: age, oral contraception,
`specific cervical infection, smoking,
`and douching. Am ] Obstttt Gynecol
`173:534, 1995.
`
`327. Crarn.c.r DW, Gold.cnan MB, Schiff I,
`Belisla S, Albrecht B, Sradd B,
`Gibson M, Wtlsoo. E, Scillm.an R.
`Thompson I, T he relationship of
`tubal infercilicy to barrier merhod and
`JAMA
`oral
`conr..racepcivc
`\!Se,
`257:2446, 1987.
`
`328. Wolner-Hanssen P, Bsche.ubach DA,
`Pa:rvooe.n J, Kiviar N, Scevens CE,
`Critchlow C, DeRouen T, Holmes
`KK, Decreased r.isk of symptomatic
`chlamydial
`pelvic
`inflammatory
`disease associated wirn oral contracep(cid:173)
`tive use, ]AMA 263:54, 1990.
`
`329. Ness RB, Kede.r LM, Sope.r DE,
`Amortegu.i AJ, Gluck J, Wiesenfdd
`H, Sweet RL, Rice PA, Peipcn: JF,
`Donegan SP, Kaobour. Shakir A. O ral
`contracepcion and the recognition of
`endomecritis, Am J Ohstn Gyn~col
`176:580, 1997.
`
`330. Barbone F, Austin H, Louv WC,
`Alc:xander 'WJ, A follow-up scudy of
`methods of conuaception, s~uai
`accivicy, aDd ntes of trichomoniasis,
`CaL!;didiasis, and bacterial vaginosis,
`Am] Obsrer ~col163:510, 1990.
`
`331. Sb.ouhnikova M, Hellberg D, Nilsson
`S, Mardh P-A, Contraceptive w e in
`women wich haccc:riai vaginosis,
`Contrauption 55:355, 1997.
`332. Becke.r WJ, Migraine and oral contra·
`a:prives, Can ] N=rol Sci 24:16,
`1997.
`
`333. Ross RK, Pike MC, Vessey MP, Bull
`D, Yeates D, Casagrande JT, Risk
`factors for urerioc fihroids: Reduced
`risk associared wich oral conrracep(cid:173)
`Jives, Br Medj 293:3 59, 1986.
`
`Mylan v. Warner Chilcott IPR2015-00682
`WC Ex. 2005, Pg. 114
`
`

`
`II
`
`317. Ahma JC, Ch.a.odta A, Mosher WD
`Peterson L, Piccinino L, (Centers fo;
`Disease Control and Prevenrioo,
`National Center For He:~.th Srarimcs),
`Fenility. family planning. and women's
`he:a.lrh: new data from
`the 1995
`National Su.rvg of Family GroWlh,
`Report No. 19. Suies 23, 1997.
`
`318. Wesuom I, Incidence, prevalence, and
`trends of arute pelvic in£l.arn.matory
`disease and its oonsequences in indUs(cid:173)
`trialized countries, Am j Obsw
`Gy.necoll38: 880, 1980.
`
`319. Eschenbach DA, Harnisch
`JP,
`Holmes KK, Pathogenesis of acute
`pelvic inflammatory disease: role of
`contraception and ocher risk factors.
`Am j Obst~t GJ~col 128:838, 19n.
`
`320. Rubin GL, Ory WH, l.ayde PM,
`Oral contracepcives and pelvic inflam(cid:173)
`.roarory disease, Am J Obrta Gyn~col
`140:630. 1980.
`
`321. Senanaya.ke
`P, Kramer DG,
`Contraception and ilie etiology of
`pelvic inflamm.uory diseasc:s: new
`perspectives, Am J Obsut Gynecol
`138:852, 1980.
`
`322. Pa.o.&C!: LA, Phipps WR, Type of oral
`contraceptive in relation to acu;:c,
`iuicial episodes of pelvic inflammatory
`disease, Contrattption 43:91, 1991.
`323. Svensson L, Westrom L. Mardh P,
`Coocracepcives and acute salpingitis,
`lAMA 251:2553, 1984.
`
`324. Wolner-Hanssen P. Oral concraceJr
`live use modifies the man.iffscacions of
`pelvic inflammatory dis~ase, Br j
`Obstrt (~matco/93:619, 19&6.
`325. Cates Jr: W. Washington AE, Rubio
`GL, Peterson HB, The pill, chlamydia
`and PID, Fam Plo:nn P=pect17:175.
`1985.
`
`f
`
`f
`
`f
`f
`
`326. Ccitchlaw CW, Wiilner-Hansse.n P,
`Eschenbach DA, Kiviat NB, Kouuky
`I<K,
`LA, Stevens CE., Holmes
`Determinam:s of cervical ectopia and
`of cervicitis: age, oral conuacepcion,
`specific cervical infection, smoking.
`and douching, Am j Obmt Gynecol
`173:534, 1995.
`
`327. Cramer DW, Goldm.a.o. MB, Sc.b..iff I,
`Belisla S, Albrecht B, Stadel B,
`Gibson M, Wt..lson E., Stillman R,
`Tb.ompsoo I, Th~ rdalionship of
`rubal infertility to barrier mechod and
`]AMA
`oral
`conrracept.ive
`use,
`257:2446, 1987.
`
`328, Wolner-Hanssen. P, Eschenbach DA,
`Paavooen J, Kiviat N, Stevens CE,
`Critchlow C, DeRouc.o T, Holmes
`KK, Decreased risk of syrnptom:ttic
`chlamydia!
`pdvic
`inflammatory
`disease associated with oral contr.J<ep(cid:173)
`t.ive use,JAMA 263:54, 1990.
`
`329. Ness RB, Kede.r LM. Soper DE,
`Amortegui AJ, Gluck J, Wie&e.ofeld
`H, Sweet RL, Rice PA, Peiperr JF,
`Donegan SP, l<anhou.r-Sbakir A, Oral
`contr.~oeption and che reoognit:.ion of
`tndomwitis, Am j Obstet Gyrucol
`176:580. 1997.
`
`330. Barbone F, Austin H, Lonv WC,
`Al=dc:r WJ, A follow-up study of
`mechods of contraception, so:uaJ
`activ:icy, and rates of uichorooniasis,
`candidiasis. and bacterial vaginosis,
`Am] Obstet Gynuvl163:510, l990.
`
`331. Shoubnikova M, HeUberg D, Nilsson
`S, Mirdh P-A, Conuaceptive use in
`women with bacterial vaginosis,
`Conr:raaprion 55:355, 1997.
`332. Becker WJ, Mign.i.oe and oral conrra(cid:173)
`ceptives, CAn J Neurol Sci 24:16,
`1997.
`
`333. Ross RK, Pike MC, Vessey MP, Bull
`D , Yeates D, Casagrande ]T, Risk
`faaors ror Uterine fibroids: Reduced
`risk associated with oral oont:ra.ccp(cid:173)
`tives, Br M~dj 293:359, 1986.
`
`}
`
`"•
`
`;.~-
`~--'1.. .
`
`,, ,.,
`···:. ..
`.::·':l·
`
`Oral Contraception
`
`334. Parazzioi F, Negri E., La Vecchia C,
`Fedele L, Rahaion:i M, Luc.h.in.i L.
`Oral concracepcive use and risk of
`fibroids, Obsta Gynuol
`uterine
`79:430, 1992.
`
`335. Samad.i AR, Lee NC, Flanders D,
`Boring BI JR, Parris EB, Risk factors
`for sdf-reporred uterine .fibroids: a
`case-control stUdy, Am j Pub!.U H~alth
`86:858, 1996.
`
`336. Marshall LM, Spiegelman D,
`Goldman MB, Man~on JE, Colditz
`GA, Barbieri RL, Stampfer MJ,
`Hunter DJ, A prospective srudy of
`reproductive faaors and oral contra(cid:173)
`ceptive use in relacion tO the risk of
`uterine leiomyomata, F~il Stt:ril
`70:432, 1998.
`
`33 7. Cbiaffarino F, Parazzini F, LaVecchia
`C, Marsico S, Sll!;3ee M, Ricci E, Use
`of oral concracept..ives and urerine
`fibroids; results from a case-control
`study, Br J Obr:tn g)'1UUcol 106:857,
`1999.
`338. Friedman AJ, Thomas PP, Does low(cid:173)
`dose combination oral coocracepcive
`use affect uterine size or menstrual
`flow in premenop:>.u.sal women 'Wiili
`lciomyoro.as?, Obsut Gynecol 85:631,
`1995.
`339. Maruon RH, Cra.m.eJ: JA. Darney
`PD, Naftolin F, Use of oral c:onuacep(cid:173)
`rives by women with epilepsy, ]AlvfA
`256:238, 1986 .
`
`340. Mibom I, Sundell G, Ande.rsch ,B, A
`long1rud.inal study of concracepcion
`and pregnancy outcome in a represen(cid:173)
`tative sample of young Swedish
`women, Conmu:eption 43:111, 1991 .
`
`341. Lerrerie GS, Chow GE, Effeet of
`"missed" pilli on oral contraceptive
`effectiveness, Obstn Gynaol 79:979,
`1992.
`
`Mylan v. Warner Chilcott IPR2015-00682
`WC Ex. 2005, Pg. 115
`
`

`
`A Clinical Guide for Contraception
`
`II
`
`342. Potter L, Oakley D, de.Leon-Wong
`E, Cafiamar R, Measuring compliance
`among oral conuaceptive users, Pam
`Plann Pmptct 28:154, 1996.
`
`343. Killick SR, Bancroft K, Oelbaum S,
`Morris J, Elstei.n M, Extending the
`duration of the pill-free interval
`during combined oral contraception,
`Adv CO?Jtrttcept 6:33, 1990.
`344. F..loma.a K, Rolland R. Brose.os I,
`Moorrees M, Deprest J, Tuomineu J,
`Liht<Xnmaki P, Omining the fim oral
`contraceptive piUs of the cycle does
`nor automatically lead to ovulation.
`Am] Obnet Gymcol 179:41, 1998.
`
`345. van. Heusdeu AM, Pause.r BC]M,
`.A£:Uvicy of che piruiwy-ovarian axis i.n
`the pill-free interval during use of low(cid:173)
`dose combined oral contn.cepcives,
`Contrtueption 59:237, 1999.
`
`346. Jung-Hoffman C, Kuhl H, Intra- and
`incerindividual variations in oonua(cid:173)
`ceptivc steroid
`levels during 12
`creacmem cycles: no relarioo to irregu(cid:173)
`lar bleedings, Contraception 42:423,
`1990.
`347. Endrikat J, Miiller U, Dilsterberg B.
`A rwelve-mont.h oomp:uacivc clinical
`investigation of two low-dose oral
`contraceptives containing 20 pg
`ethinylestradioU75 jlg ge:srodea.e and
`30 J.Ig ~nylcsrrad.i.oU75 pg gcsro(cid:173)
`dene, wim respea ro efficacy, cycle
`concrol, and mler:mce, Contraception
`55:131, 1997.
`
`348. RDsenberg MJ, Waugh MS, Stevens
`CM, Smokiog and cycle conu-ol
`among oral contraceptive users, Am J
`Obstet Gyncc~/174:628, 1996.
`
`349. Rosenberg MJ, Waugh MS, Higgins
`JE, The effect of dcsogemd, gesto(cid:173)
`denc, and other factors on spotting
`and bleeding, Contra.uptum 53:85,
`1996.
`
`350. Krettdc SE, Arkin SI, Chaisilwattau.a
`P, Monif GR, ChlamydUt trachomo.ti.r
`in patients who used oral concracep(cid:173)
`cives aod had inrermensrrual sporting.
`Obst~t cry,uco/8!: 728, 1993.
`
`351. Palaui R, Hi.rvensalo E, Liukko P,
`Malmiliarju T, Mactila L, Riihiluoma
`P, Ylostalo P, Serum
`total and
`and
`sex
`unbound
`cesmm:rone
`b.ormooe bindiog globulin (SHBG) in
`female acne patients creared wirh two
`different oral contraceptives, Acta
`Dff1/2 Venmo/64:517. 1984.
`
`352. Lemay A. Dewailly SD, Grenier R,
`Huard J, Attenuarion of mild hyper(cid:173)
`androgenic acrivity in postpubem.l
`acne by a triphasic oral conrracepcive
`
`courain.i.ng low doses of erhynyl =(cid:173)
`diol and d,l-oorgesrrel, J Clin
`Endocrinol Mrub 71:8, 1990.
`
`353. Mango D, Ricci S, Manna P,
`Miggiano GAD, Sen-a GB, Clinical
`and hormooal effects of ethinyl estra(cid:173)
`diol combined wirh gtstodene and
`desogestrel in young women with acne
`vulgaris, Contraception 53:163, 1996.
`
`354. Redmond GP, Olson WH, Lppman
`]S, Kafrissen ME, Jones TM, Joriz:zo
`JL, Norgescimate and ethi.uyl emadiol
`in th.e creacmeot of acne vulgaru: a
`randomi7.ed, placebo-<:ontrolled uial,
`Obsut Gyntco/89:615, 1997.
`
`355. Lucky AW, Henderson TA. Olson
`WH, Robisch DM, Lebwohl M,
`Swin.yec LJ, Effectiveness of norgesci(cid:173)
`mace and e-.hinyl escradiol in uearing
`moderate ac.ne vulgaris, J Am Acad
`Damato/37:746, 1997.
`
`356. Grimes DA, Hughes JM, Use of
`multiphasic or:tl contraceptives and
`hospirali:z.acions of women wit:h func·
`in the United
`donal ovarian cysts
`Scates, Obmt Gyntco/ 73: 1037 , 1989.
`
`357. Vessey M, Mcrcalfe A, Wells C,
`McPhe.rson I<, Westhoff C, Yeates C,
`Ovarian neoplasms, funcrional ovar(cid:173)
`ian cysts, and or<!.~ concracepcivcs, Br
`Md]294:1518, 1987.
`
`358. Lanes SF, Birmann B, Walker AM,
`Singer S, Oral oontraceprive type and
`functional ovarian cysts, Am] Obstet
`~co/166:956, 1992.
`
`359. Holt VL, Dallog JR, McKnight B,
`Moore D, Stergachis A, Weiss NS,
`Functional ovarian cysts in relation to
`rhe use of monophasic and triphasic
`oral contraceptives, Obstet Gynecol
`79:529, 1992.
`
`360. Youog RL, Snabes MC, Frank ML,
`Reilly M, A randomized, double(cid:173)
`blind, placcbo-conuolled comparison
`of tb.e i.mpacr of low-dose and uipha(cid:173)
`sic. ora! concaceptives on follicular
`developmenr, Am J Obttet Gyn~col
`167:678, 1992.
`
`36l. Grimes DA. Godwin AJ, Rubin A,
`Smith JA, Lacarra M , Ovulation and
`follicular development associated wirh
`rhree low-dose oral contraccprives: a
`random.i:l.cd controlled erial, Obsut
`Gyncco/83:29, 1994.
`
`362. Nedy JL, Abate M, Swjnker M,
`D'Angio R, The effect of doxycycline
`on serwn levels of ethinyl estradiol,
`noreLhindcone,
`and
`endogenous
`prog=crone, Obstet Gynuol 77:416,
`1991.
`
`363. Mu.rpby AA, Zacur H.A, Charache P,
`Burkman RT, The dfecr of tetracy(cid:173)
`cline on levds of oral comraocpcivcs,
`Am] Obmt Gyn~col164:28, 1991.
`364, Back DJ, Tija J, ManioC, Millar E.
`Man.t T, Morrison P, Orme P, The
`lack of interaction baween tema(cid:173)
`flo:racin
`and
`combined
`o ral
`concraceptive steroids, Contrauption
`43:3 17, 1991.
`
`Mylan v. Warner Chilcott IPR2015-00682
`WC Ex. 2005, Pg. 116
`
`

`
`II
`
`350. Krett:ek SE, Arkin Sl, Cha.is.ilwattana
`P, Monif GR, Chlamydia tnuhonuuiJ
`in pat..iau:.s who ·used. oral conlraccp(cid:173)
`tives and had intermenstrual spotcing,
`Obsta G;nucoi 81:728, 1993.
`
`351. Palatsi R, Hlrvensalo E, Liukko P,
`Malmiharju T, Matcila L, Riihiluoma
`P, Ylostalo P, Serum
`total and
`unbouod
`testosterone
`and
`sex
`hormone binding globuLn (SHBG) in
`female acne patienrs created with two
`ditfcrenr oral concracepcives, Acca
`Dmn VC12&Tr"ol64:517, 1984.
`
`352. Lemay A, Dewailly SD, G«:n.ier R,
`Huard J, Attenuation of mild hyper(cid:173)
`androgenic accivicy in poscpube.rtal
`acne by a uipha.sic oral coutracepcive
`c.onca.ining low doses of ewynyl escra(cid:173)
`dioJ and d ,l-norgesrrd, J Clin
`EndocrinolM~<Utb 71:8, 1990.
`
`353. Mango D, Ricci S, Manna P,
`Miggiano GAD, Serra GB, Clinic.al
`and hormonal effects of ethioyl esrra(cid:173)
`diol combined wich gesrodene aud
`desogesuel in young women wim acne
`vulgaris, Conrraceptum 53: 163, 1996.
`
`354. Redmond GP, Olson WH, Lippman
`]S, Kafrissea ME, Jones TM, Jorizzo
`JL, Norgcsrimatt:: and eth.inyl estradiol
`in the t:.rea rmen t of acne vulgaris: a
`raudomi.za!, placcbo-concrolled trial,
`Obstet Gyneco/89:615, 1997.
`
`355. Lucky AW, Henderson TA, Olson
`WH, Robisch DM, Lebwohl M,
`S-winyer LJ, Effectiveness of oorgr.sci(cid:173)
`mate and erhinyl estradiol in neating
`moderate acne vulgaris, J Am Auui.
`Dn-mato/37:746, 1997.
`
`356. Grimes DA, Hughes JM, Use of
`muhipbasic oral contr:~cepcives and
`hospital..izarions of women with func(cid:173)
`tional ovarian cysts in the United
`Srar.es, Obstet Gyneco/73:1037, 1989.
`
`.· ..... · ' •
`
`··~
`: .··-
`' . ~>
`
`. ,,
`·-···
`
`......
`. ;.,~
`
`'
`
`···.
`. ·:·'
`
`357. Vessey M, Metcalfe A, Wells C,
`McPherson K. Westhoff C, Yea~ C,
`Ovarian neoplasms, functional ovu(cid:173)
`ian cyru, and oral contr:~ccpcivcs, Br
`Mcd]294:l518, 1987.
`
`358. Lanes SF, Bi.nnann B, Walker AM,
`Singer S, Oral contraceptive type and
`fu.oction.al ovarian cyscs, Am ] Obsret
`Gyne,o/166:956, 1992.
`359. Hole VL, Daling JR McKnight B,
`Moore D, Scergachis A. Weiss NS,
`Functional ovarian cysts in rdarion ro
`the use of monophasic and triphasic
`oral cono:aceptives, Obrtet Gynecol
`79:529, 1992 .
`
`360. Young RL, Snabes MC, Frank ML,
`Reilly M, A randomized, double(cid:173)
`blind, placebo-controlled comparison
`of the impact of low-dose and tripha(cid:173)
`sic oral CllJlt":lceptives on follicular
`development, Am J Obsta Gyru•ol
`167:678, 1992.
`
`361. Grimes DA, Godwin AJ, Rubio A,
`Sm.im JA, Lacaua M, OvuJation and
`follicular development associated with
`three low-dose oral contracepcives: a
`randomized conuolled uial, Obstet
`Gy~co/83:29, 1994.
`
`362. Neely JL, Abare M, Swinkc:r M,
`D'Angio R, The effecr of doxycycline
`on serum levds of ethinyl cscrad.iol,
`norerb..indrone,
`and
`endogenous
`progesterone, Obsta GyMcol 77:416,
`1991.
`
`363. Mwphy AA, Zacur HA. Charache P,
`Burian= RT, The effecr of recracy(cid:173)
`clint: on levels of oral conuaceptives,
`Am]Obste~ Gyneco/164:28, 1991.
`364. Back DJ, Tija J, Martin C, Millar E,
`Mant T, Morrisou P, Orme P, The
`lack of interaaion between rema(cid:173)
`floxacin
`and
`combined
`oral
`conrnceptive sreroids, Contraception
`43:317, 1991.
`
`Oral Contraception
`
`365. Csemiczky G, Alveudal C, Lmd~
`BM, Ris.k for ovulatiion in women
`taking a low-dose oral comraceprive
`(Microgynon) when rece.iving autibac(cid:173)
`rerial crearroe.nt wich a fluoroquinolonc
`(ofloncin), Adu C071tr11Cep 12:101,
`1996.
`'
`366. Helms SE, Bred.le DL, Zajic J,
`Ja.rjoura D, BrodeU RT, Krishnarao I,
`OraJ ooocracepcive failure r.ues and
`oral antibiotics, J Am ACad De77!14.UJl
`36:705, 1997.
`
`367. Szoka PR, Edgren RA, Drug interac(cid:173)
`tions with oral
`contraceptives:
`compilarioo and analysis of an adverse
`experienq; report database, Fmil Sreril
`49(Suppl):31S, 1988.
`
`368. Bard.itch-Crovo P, Trapne.ll CB, Erre
`E, Za=.r HA, <Aresh J, Rocco LE,
`Heudrix CW. Flo:ner C, The efferu
`of rihmpin and rifabucin on che phar(cid:173)
`macokinetics and. pharmacodynamics
`of a combinacion oral a:Jnoaceptive,
`Clin Phamuuol Ther 65:428